NRX Pharmaceuticals, Inc. (NRXP) analyst actions
Rating and price-target actions on NRXP in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NRXP overview →
5 measured NRXP analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine | Press release | +3.92% | -0.65% | |
| HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health | Press release | +1.79% | +1.20% | |
| NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing | Press release | +2.06% | -1.69% | |
| NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales | Press release | -3.45% | -23.81% | |
| NRx Pharmaceuticals Announces Further Alignment with FDA on Initiation of Registrational Trials for NRX-101 in the Treatment of Chronic Pain | Press release | -3.40% | +0.18% |
Keep exploring
More NRXP: earnings → · SEC filings → · NRXP overview →